[MINI-PODCAST] Ep 60: Advancing Clinical Trial Equity

Find the CANCER BUZZ podcast on Apple Podcasts, Spotify, or wherever you get your podcasts!

Increasing diversity and equity in clinical trials will require buy-in and commitment from all stakeholders in the research enterprise. In this episode, Colleen Lewis, MSN, ANP-BC, AOCNP, talks about the critical role oncology advanced practitioners can play in moving the needle on equity and inclusion in cancer clinical trials.

In spring 2021, ACCC and Harborside hosted a Virtual Summit to Define on the Role Oncology Advanced Practitioners in Equitable Cancer Care Delivery. Each summit session focused one specific domain of care delivery—Care Coordination and Communication; Clinical Trials; and Acknowledging and Mitigating Implicit Bias.   

“I think it’s critically important for clinicians to really be aware of the concept of implicit bias as we’re assessing patients for trials.”

Colleen Lewis, MSN, ANP-BC, AOCNP
Director of Clinical Operations, Phase I Program; Interim Director, Infusion Center Clifton
The Winship Cancer Institute of Emory University,
Atlanta, GA

This mini-podcast—and two upcoming shows—will share key themes from the Summit. Look for more findings coming soon to the ACCC website.

Related Content

• ACCC Community Oncology Research Institute
• ASCO-ACCC Initiative to Increase Racial and Ethnic Diversity in Clinical Trials
• Real World Lessons from COVID-19 [Video Podcast]
• Ep 52: End of Life Disparities [Podcast]
• Ep 51: Cultural Humility and Sensitivity [Podcast]
• Ep 49: Building Trust with Marginalized Groups [Mini-Podcast]
• In Pursuit of Equity: Diversity in Clinical Research Participation [Webinar]
• Practical Solutions to Better Engage Cancer Professionals with Communities of Color [Webinar]
• Implementation of a Health Disparities & Equity Program at the Duke Cancer Institute,
• Paving the Way for APPs in Clinical Research
• [Abstract 95] Role of Oncology Advanced Practitioners to Enhance Clinical Research
• Research Review: Making Clinical Trials More Inclusive, Diverse, Accessible, and Representative
• Phase 1 Clinical Trials in the Elderly: Enrollment Challenges
• Bias and stereotyping among research and clinical professionals: perspectives on minority recruitment for oncology clinical trials

Thank you to Pfizer Oncology for their collaboration and support in hosting the ACCC-Harborside Virtual Summit.